Alzheimer’s – Panel Discussion

Date: 2022-05-04

On May 3, Kristina Torfgård, CEO, and Anders Sandberg, CSO participated in a panel discussion on Alzheimer's disease.

Alzinova, Alzecure and BioArctic participated in a panel discussion arranged by Redeye. The discussion focused on the science behind the companies’ drug candidates, the remaining need and what it takes to successfully launch a new generation of Alzheimer’s drugs.

Watch the discussion below.